Evidence map›Paper›PMID 31664461›Full record

ArticleCellular and molecular life sciences : CMLS2020

Annexin A6 modulates TBC1D15/Rab7/StARD3 axis to control endosomal cholesterol export in NPC1 cells.

Elsa Meneses-Salas, Ana García-Melero, Kristiina Kanerva, Patricia Blanco-Muñoz, Frederic Morales-Paytuvi, Júlia Bonjoch, Josefina Casas, Antonia Egert, Syed S Beevi, Jaimy Jose and 10 more

Open access · hybridAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Revisiting the role of Annexins in membrane trafficking.Cellular and molecular life sciences : CMLS · 2025
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Niemann-Pick Disease Type C (NPDC) by Mutation ofAntioxidants (Basel, Switzerland) · 2023
    Review
  20. Intracellular Cholesterol Trafficking.Cold Spring Harbor perspectives in biology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 5 countries.

Elsa Meneses-SalasDepartament de Biomedicina, Unitat de Biologia Cel·lular, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, 08036, Barcelona, Spain.
Ana García-MeleroDepartament de Biomedicina, Unitat de Biologia Cel·lular, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, 08036, Barcelona, Spain.
Kristiina KanervaFaculty of Medicine, Anatomy, University of Helsinki, 00014, Helsinki, Finland.
Patricia Blanco-MuñozDepartament de Biomedicina, Unitat de Biologia Cel·lular, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, 08036, Barcelona, Spain.
Frederic Morales-PaytuviDepartament de Biomedicina, Unitat de Biologia Cel·lular, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, 08036, Barcelona, Spain.
Júlia BonjochDepartament de Biomedicina, Unitat de Biologia Cel·lular, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, 08036, Barcelona, Spain.
Josefina CasasResearch Unit on BioActive Molecules (RUBAM), Department of Biological Chemistry, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Barcelona, Spain.
Antonia EgertSchool of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, 2006, Australia.
Syed S BeeviSchool of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, 2006, Australia.
Jaimy JoseSchool of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, 2006, Australia.
Vicenta Llorente-CortésLipids and Cardiovascular Pathology Group, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.
Kerry-Anne RyeSchool of Medical Sciences, University of New South Wales, Sydney, NSW, 2052, Australia.
Joerg HeerenDepartment of Biochemistry and Molecular Biology II: Molecular Cell Biology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Albert LuDepartment of Biochemistry, Stanford University School of Medicine, Stanford, USA.
Albert PolDepartament de Biomedicina, Unitat de Biologia Cel·lular, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, 08036, Barcelona, Spain.
Francesc TebarDepartament de Biomedicina, Unitat de Biologia Cel·lular, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, 08036, Barcelona, Spain.
Elina IkonenFaculty of Medicine, Anatomy, University of Helsinki, 00014, Helsinki, Finland.
Thomas GrewalSchool of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, 2006, Australia. thomas.grewal@sydney.edu.au.ORCID http://orcid.org/0000-0002-7937-8887
Carlos EnrichDepartament de Biomedicina, Unitat de Biologia Cel·lular, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, 08036, Barcelona, Spain. enrich@ub.edu.ORCID http://orcid.org/0000-0003-0382-2993
Carles RenteroDepartament de Biomedicina, Unitat de Biologia Cel·lular, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, 08036, Barcelona, Spain. carles.rentero@ub.edu.ORCID http://orcid.org/0000-0003-4684-0278
Departament de Salut · ESThe University of Sydney · AUUniversity of Helsinki · FIInstitució Catalana de Recerca i Estudis Avançats · ESInstitute of Advanced Chemistry of Catalonia · ESInstituto de Salud Carlos III · ESStanford University · USUniversität Hamburg · DEUNSW Sydney · AU

Funding

Academy of Findland 282192Academy of Finland 307415Academy of Finland 312491Secretaría de Estado de Investigación, Desarrollo e Innovación BFU2015-66785-PSecretaría de Estado de Investigación, Desarrollo e Innovación CSD2009-00016University of Sydney RY253University of Sydney U3367University of Sydney U7113
6 · The paper itself

Abstract

Cholesterol accumulation in late endosomes is a prevailing phenotype of Niemann-Pick type C1 (NPC1) mutant cells. Likewise, annexin A6 (AnxA6) overexpression induces a phenotype reminiscent of NPC1 mutant cells. Here, we demonstrate that this cellular cholesterol imbalance is due to AnxA6 promoting Rab7 inactivation via TBC1D15, a Rab7-GAP. In NPC1 mutant cells, AnxA6 depletion and eventual Rab7 activation was associated with peripheral distribution and increased mobility of late endosomes. This was accompanied by an enhanced lipid accumulation in lipid droplets in an acyl-CoA:cholesterol acyltransferase (ACAT)-dependent manner. Moreover, in AnxA6-deficient NPC1 mutant cells, Rab7-mediated rescue of late endosome-cholesterol export required the StAR-related lipid transfer domain-3 (StARD3) protein. Electron microscopy revealed a significant increase of membrane contact sites (MCS) between late endosomes and ER in NPC1 mutant cells lacking AnxA6, suggesting late endosome-cholesterol transfer to the ER via Rab7 and StARD3-dependent MCS formation. This study identifies AnxA6 as a novel gatekeeper that controls cellular distribution of late endosome-cholesterol via regulation of a Rab7-GAP and MCS formation.

Indexed as

AnimalsAnnexin A6Carrier ProteinsCell MembraneCHO CellsCholesterolCricetulusEndoplasmic ReticulumEndosomesGTPase-Activating ProteinsHumansMembrane ProteinsNiemann-Pick Disease, Type CProtein DomainsProtein Transportrab7 GTP-Binding ProteinsAnnexin A6Carrier ProteinsCholesterolGTPase-Activating ProteinsMembrane Proteinsrab7 GTP-Binding Proteinsrab7 GTP-binding proteins, humanrab GTP-Binding ProteinsRNA, Small InterferingSTARD3 protein, humanTBC1D15 protein, humanAnnexin A6CholesterolLate endosomesMembrane contact sitesNPC1Rab7

Identifiers

PMID31664461
PMCPMC7326902
OpenAlexW2982456101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.